Luyan Pharma Co.,Ltd. (SHE:002788)

China · Delayed Price · Currency is CNY

10.57

+0.37 (3.63%)

Aug 3, 2026, 3:05 PM CST

21.91% (1Y)

Market Cap	4.11B +21.8%
Revenue (ttm)	21.42B +4.5%
Net Income	277.50M -16.7%
EPS	0.71 -16.4%
Shares Out	388.52M
PE Ratio	14.89
Forward PE	n/a
Dividend	0.35 (3.43%)
Ex-Dividend Date	Jul 10, 2026

Volume	16,081,612
Open	10.39
Previous Close	10.20
Day's Range	9.89 - 10.58
52-Week Range	7.90 - 28.29
Beta	-0.01
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 18, 2026

About Luyan Pharma

Luyan Pharma Co.,Ltd., together with its subsidiaries, engages in the research, development, production, and sale of pharmaceutical products, and prepared slices of traditional Chinese medicine in China. The company distributes medicines, Chinese herbal medicines, medical devices, and others; and provides medical care, elderly care, and wellness services. It also operates pharmaceutical retail chains. The company was formerly known as Luyan (Fujian) Pharma Co. Ltd. and changed its name to Luyan Pharma Co.,Ltd. in June 2016. Luyan Pharma Co.,Ltd... [Read more]

Industry Pharmaceutical Retailers

Sector Healthcare

Founded 1992

Employees 5,722

Stock Exchange Shenzhen Stock Exchange

Ticker Symbol 002788

Full Company Profile

Financial Performance

In 2025, Luyan Pharma's revenue was 21.25 billion, an increase of 3.79% compared to the previous year's 20.47 billion. Earnings were 280.88 million, a decrease of -18.74%.

Financial Statements